SCHEMBL7654099

SCHEMBL7654099

O=c1ccc2ccc(OCc3ccccc3)cc2[nH]1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 6/20 0.79
ACHE P22303 1/20 0.79
ALOX5 P09917 1/20 0.58
CTSV O60911 2/20 0.58
CTSL P07711 2/20 0.58
NSD2 O96028 1/20 0.55
ABL1 P00519 1/20 0.55
PPARG P37231 1/20 0.55
RIN1 Q13671 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
NCOR2 Q9Y618 1/20 0.55
MAOA P21397 5/20 0.54
MEN1 O00255 1/20 0.54
NPC1 O15118 1/20 0.54
CA12 O43570 1/20 0.54
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
CA3 P07451 1/20 0.54
CA4 P22748 1/20 0.54
CA6 P23280 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30507458 1.00 MAOB (0.79) MAOBACHEALOX5CTSVCTSL
SCHEMBL3373971 0.90 MAOB (0.65) MAOBACHEALOX5CTSVCTSL
SCHEMBL5143597 0.89 MAOB (0.65) MAOBACHEALOX5CTSVCTSL
SCHEMBL30712216 0.79 DRD2 (0.57) MAOBACHE
SCHEMBL19732216 0.79 DRD2 (0.57) MAOBACHE
SCHEMBL31498189 0.79 ALOX5 (0.58) MAOBACHEALOX5CTSVCTSL
SCHEMBL9265187 0.79 ALOX5 (0.58) MAOBACHEALOX5CTSVCTSL
SCHEMBL18264073 0.79 L3MBTL1 (0.55) MAOBACHEL3MBTL1SMN1; SMN2
SCHEMBL2795363 0.78 CTSV (0.65) MAOBACHECTSVCTSLNSD2
SCHEMBL3030893 0.78 SRD5A2 (0.80) MAOBACHEALOX5CTSVCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117986244-A Quinolinone derivative and preparation method and application thereof 江苏恩华药业股份有限公司 2024-05-07 CN disclosed
CN-112010844-B Preparation method and application of N- (pyrimidine-2-yl) coumarin-7-amine derivative as protein kinase inhibitor 中国药科大学 2023-07-25 CN disclosed
CN-112010844-A Preparation method and application of N- (pyrimidine-2-yl) coumarin-7-amine derivative as protein kinase inhibitor 中国药科大学 2020-12-01 CN disclosed
US-20020022633-A1 Inhibitors of prenyl-protein transferase WILLIAMS THERESA M (US) 2002-02-21 US disclosed
WO-2002002108-A1 INHIBITORS OF PRENYL-PROTEIN TRANSFERASE MERCK & CO., INC. (US) 2002-01-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020022633-A1 Inhibitors of prenyl-protein transferase FNTA, KRAS, FNTB MAOB 4308/4885ACHE 3889/4885ALOX5 4040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.